Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Rho kinase is an effector underlying Ca2+-desensitizing hypoxic relaxation in porcine coronary artery.

Wardle RL, Gu M, Ishida Y, Paul RJ.

Am J Physiol Heart Circ Physiol. 2007 Jul;293(1):H23-9. Epub 2007 Apr 6.

2.

Smooth muscle contraction by small GTPase Rho.

Kawano Y, Yoshimura T, Kaibuchi K.

Nagoya J Med Sci. 2002 May;65(1-2):1-8. Review.

PMID:
12083286
3.
4.
5.

Role of myosin light chain phosphorylation in the regulation of cytokinesis.

Matsumura F, Totsukawa G, Yamakita Y, Yamashiro S.

Cell Struct Funct. 2001 Dec;26(6):639-44. Review.

6.

Molecular mechanisms involved in development of cerebral vasospasm.

Tani E.

Neurosurg Focus. 2002 Mar 15;12(3):ECP1. Review.

PMID:
16212317
7.

The myosin phosphatase targeting protein (MYPT) family: a regulated mechanism for achieving substrate specificity of the catalytic subunit of protein phosphatase type 1δ.

Grassie ME, Moffat LD, Walsh MP, MacDonald JA.

Arch Biochem Biophys. 2011 Jun 15;510(2):147-59. doi: 10.1016/j.abb.2011.01.018. Epub 2011 Feb 1. Review.

PMID:
21291858
8.

Rho-kinase as a potential therapeutic target for the treatment of pulmonary hypertension.

Xing XQ, Gan Y, Wu SJ, Chen P, Zhou R, Xiang XD.

Drug News Perspect. 2006 Nov;19(9):517-22. Review.

PMID:
17220956
9.

[The role of Rho/Rho-kinase pathway in smooth muscle contraction].

Li ZL, Jiang SZ.

Sheng Li Ke Xue Jin Zhan. 2005 Oct;36(4):341-4. Review. Chinese. No abstract available.

PMID:
16408776
10.

ZIP kinase, a key regulator of myosin protein phosphatase 1.

Haystead TA.

Cell Signal. 2005 Nov;17(11):1313-22. Review.

PMID:
16005610
11.

Rho-kinase and RGS-containing RhoGEFs as molecular targets for the treatment of erectile dysfunction.

Linder AE, Webb RC, Mills TM, Ying Z, Lewis RW, Teixeira CE.

Curr Pharm Des. 2005;11(31):4029-40. Review.

PMID:
16378508
12.

Regulation of myosin light chain phosphatase and pulmonary arterial relaxation.

Dakshinamurti S.

Can J Physiol Pharmacol. 2005 Oct;83(10):893-8. Review.

PMID:
16333361
13.

RhoA/Rho-kinase in erectile tissue: mechanisms of disease and therapeutic insights.

Jin L, Burnett AL.

Clin Sci (Lond). 2006 Feb;110(2):153-65. Review.

PMID:
16411892
14.

Molecular aspects of arterial smooth muscle contraction: focus on Rho.

Hilgers RH, Webb RC.

Exp Biol Med (Maywood). 2005 Dec;230(11):829-35. Review.

PMID:
16339747
15.

Regulation of myosin II during cytokinesis in higher eukaryotes.

Matsumura F.

Trends Cell Biol. 2005 Jul;15(7):371-7. Review.

PMID:
15935670
16.

RhoA/Rho-kinase as a therapeutic target in asthma.

Kume H.

Curr Med Chem. 2008;15(27):2876-85. Review.

PMID:
18991642
17.

[Identification of PI3K-C2alpha as the mediator of Ca2+-induced Rho activation and MLC phosphatase inhibition].

Takuwa Y.

Nihon Yakurigaku Zasshi. 2007 Apr;129(4):253-7. Review. Japanese. No abstract available.

PMID:
17435335
18.
19.

Hypoxic vasorelaxation: Ca2+-dependent and Ca2+-independent mechanisms.

Thorne GD, Ishida Y, Paul RJ.

Cell Calcium. 2004 Sep-Oct;36(3-4):201-8. Review.

PMID:
15261476
20.

[Regulation of myosin II in cell division and cell migration].

Matsumura F, Yamakita Y, Yamashiro S.

Tanpakushitsu Kakusan Koso. 2006 May;51(6 Suppl):566-72. Review. Japanese. No abstract available.

PMID:
16719313

Supplemental Content

Support Center